First real-world studies report glecaprevir/pibrentasvir to be effective and well tolerated in chronic HCV infection
The results of the first real-world studies assessing the effectiveness and safety of glecaprevir/pibrentasvir (G/P) in patients with chronic hepatitis C virus (HCV) infection have confirmed high rates of viral suppression ...
Apr 12, 2018
0
1